Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.81 USD | -0.24% | -3.98% | -19.33% |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 10 | Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform | MT |
Financials (USD)
Sales 2024 * | 631M | Sales 2025 * | 768M | Capitalization | 5.96B |
---|---|---|---|---|---|
Net income 2024 * | -565M | Net income 2025 * | -501M | EV / Sales 2024 * | 9.27 x |
Net cash position 2024 * | 111M | Net Debt 2025 * | 223M | EV / Sales 2025 * | 8.05 x |
P/E ratio 2024 * |
-10.4
x | P/E ratio 2025 * |
-12.1
x | Employees | 927 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.14% |
Latest transcript on Ionis Pharmaceuticals, Inc.
1 day | -0.24% | ||
1 week | -3.98% | ||
Current month | -5.86% | ||
1 month | -2.90% | ||
3 months | -19.43% | ||
6 months | -11.24% | ||
Current year | -19.33% |
Managers | Title | Age | Since |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 12-06-30 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 00-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 14-02-02 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Joan Herman
BRD | Director/Board Member | 70 | 19-06-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.89% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 40.81 | -0.24% | 990,649 |
24-04-17 | 40.91 | -1.52% | 1,176,174 |
24-04-16 | 41.54 | -0.02% | 1,101,462 |
24-04-15 | 41.55 | -0.46% | 789,558 |
24-04-12 | 41.74 | -1.79% | 829,857 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.33% | 5.96B | |
-1.82% | 41.36B | |
+44.25% | 41.3B | |
+2.56% | 39.61B | |
-12.11% | 25.62B | |
+3.09% | 24.09B | |
-24.16% | 18.38B | |
+22.12% | 11.85B | |
-3.74% | 11.82B | |
+7.75% | 11.07B |
- Stock Market
- Equities
- IONS Stock